EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Systemic Inflammation and CAR-T Specific Toxicities as Major Drivers of Nonrelapse Mortality: Analysis from the Italian Prospective Observational CART-SIE Study

Angelica Barone, Federico Stella, Silva Ljevar, Beatrice Casadei, Stefania Bramanti, Patrizia Chiusolo, Alice Di Rocco, Maria Chiara Tisi, Ilaria Cutini, Piera Angelillo, Massimo Martino, Maurizio Musso und 19 weitere

Transplantation and Cellular Therapy · 2026

DOI: 10.1016/j.jtct.2026.02.048 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplantation and Cellular Therapy, 2026. Verfasst von Angelica Barone und 30 weiteren Autor:innen. Beteiligte Einrichtung: University of Milan, Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy; Division of Hematology and Stem Cell Transplant…. Hauptthemen laut MEDLINE: Inflammation, Immunotherapy, Adoptive, Lymphoma, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italian Association Against Leukemia-Lymphoma and Myeloma ONLUS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chimeric antigen receptor (CAR)-T cell therapy has revolutionized outcomes in relapsed/refractory lymphomas, yet nonrelapse mortality (NRM) has emerged as a notable concern, with older age and infections identified as major determinants of NRM in real-life studies. OBJECTIVE: The aim of the present study was to describe the rate and causes of NRM after CAR-T cells and identify risk factors. STUDY DESIGN: Within the framework of the prospective, multicenter, observational CART‑SIE study, we analyzed causes and determinants of NRM in a large real-world cohort of lymphoma patients receiving CAR‑T cells from 2019 to 2025. Associations between NRM and clinical or biological factors were assessed using Fine and Gray subdistribution hazard models. RESULTS: From 2019 to 2025, 1132 patients were enrolled in the CART-SIE Study; among those, 932 were evaluable for outcomes, with a median follow-up of 17.8 months (IQR 6.3-25.4). In this cohort, 305 deaths were observed, mainly occurring after disease progression (n = 258); overall, 47 deaths were solely attributable to NRM (5%), either early (≤28 days, 40.4%), late (29-90 days, 23.4%) or very late (>90 days, 36.2%). The 1- and 2-year cumulative incidence of NRM were 5.5% and 8.8%. Infections were the leading cause (51%), followed by CAR-T acute toxicities (CRS, ICANS, and HLH/MAS; 30%), and secondary malignancies (11%). In univariable analysis, age > 60 gt; 60 years, diabetes, atrial fibrillation, high CAR-HEMATOTOX score, elevated ferritin, baseline cytopenias, CRS grade ≥3, any-grade or grade ≥3 ICANS and infectious events were risk factors for NRM. Multivariable models revealed that, among pre-infusion factors, only high ferritin levels (HR 3.23, 95% CI: 1.37-7.62, P = .007) and diabetes (HR 3.93, 95% CI: 1.28-12.1, P = .017) independently predicted NRM, while only severe CRS, ICANS, and infections remained strong post-infusion predictors. CONCLUSIONS: These findings emphasize the role of host-related factors and inflammation in shaping CAR-T outcomes. Optimized patient selection, rigorous management of acute toxicities, tailored infectious prophylaxis and long-term oncologic surveillance are essential components of long-term survivorship care, aiming to mitigate NRM and sustain long-term benefits of CAR-T cells. Clinical trial registration ClinicalTrials.gov ID: NCT06339255.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationImmunotherapy, AdoptiveLymphomaReceptors, Chimeric AntigenHumansMaleFemaleProspective StudiesMiddle AgedItalyAgedRisk Factors

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • University of Milan, Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • University of Milan, Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy. Electronic address: federico.stella@unimi.it.
  • Department of Data Science, Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Transplantation Unit Department of Oncology and Haematology, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Dipartimento di Scienze Ematologiche e di laboratorio, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Sezione di Ematologia, Ematologia e Trapianto, Università Cattolica del Sacro Cuore, Rome, Italy.

Förderung

  • Ministero della Salute
  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
  • Italian Association Against Leukemia-Lymphoma and Myeloma ONLUS
  • AIRC Foundation for Cancer Research
  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Barone, A., Stella, F., Ljevar, S., Casadei, B., Bramanti, S., Chiusolo, P., Rocco, A. D., Tisi, M. C., Cutini, I., Angelillo, P., Martino, M., Musso, M., Farina, M., Pennisi, M., Barbui, A. M., Freilone, R., Olivieri, J., Grillo, G., Musto, P., …, & Corradini, P. (2026). Systemic Inflammation and CAR-T Specific Toxicities as Major Drivers of Nonrelapse Mortality: Analysis from the Italian Prospective Observational CART-SIE Study. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2026.02.048

Vancouver

Barone A, Stella F, Ljevar S, Casadei B, Bramanti S, Chiusolo P, et al. Systemic Inflammation and CAR-T Specific Toxicities as Major Drivers of Nonrelapse Mortality: Analysis from the Italian Prospective Observational CART-SIE Study. Transplantation and Cellular Therapy. 2026. doi:10.1016/j.jtct.2026.02.048

BibTeX
@article{Barone2026,
  author = {Barone, Angelica and Stella, Federico and Ljevar, Silva and Casadei, Beatrice and Bramanti, Stefania and Chiusolo, Patrizia and Rocco, Alice Di and Tisi, Maria Chiara and Cutini, Ilaria and Angelillo, Piera and Martino, Massimo and Musso, Maurizio and Farina, Mirko and Pennisi, Martina and Barbui, Anna Maria and Freilone, Roberto and Olivieri, Jacopo and Grillo, Giovanni and Musto, Pellegrino and Saraceni, Francesco and Krampera, Mauro and Brunello, Lucia and Castellino, Alessia and Ragaini, Simone and Arcaini, Luca and Chiappella, Annalisa and Guidetti, Anna and Dodero, Anna and Miceli, Rosalba and Zinzani, Pierluigi and Corradini, Paolo},
  title = {Systemic Inflammation and CAR-T Specific Toxicities as Major Drivers of Nonrelapse Mortality: Analysis from the Italian Prospective Observational CART-SIE Study},
  journal = {Transplantation and Cellular Therapy},
  year = {2026},
  doi = {10.1016/j.jtct.2026.02.048}
}
Kostenlos starten →